Financials
- Market Capitalization 3.68 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 1477 | RLAY Relay Therapeutics, Inc. - Common Stock | 17.35 USD | -3.50% | -5.09% | -8.44% | +183.50% | 3.80 B USD | ||
| 1487 | ABCL AbCellera Biologics Inc. - Common Shares | 12.52 USD | -0.95% | -5.51% | +17.34% | +126.81% | 3.84 B USD | ||
| 1556 | VCYT Veracyte, Inc. - Common Stock | 43.59 USD | -0.98% | -2.00% | +6.11% | +18.13% | 3.50 B USD | ||
| 1564 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 34.64 USD | -3.27% | -3.86% | -41.64% | -15.08% | 3.35 B USD |